ESG
It’s time for ovary-action
Each year over 1,510 women in Australia will be diagnosed with ovarian cancer.
In the past 30 years, other cancers have been able to achieve amazing improvements in awareness, funding and survival rates and we want the same hope for all women. While some progress has been made for ovarian cancer there is still so much we need to do.
For the state of ovarian cancer to improve, we need major changes in awareness, treatment and funding. We need teal to have its time in the spotlight. We need all Australians to stand with us and take action.
Ovarian Cancer Awareness Month is held each year in Australia to raise awareness of the signs and symptoms of ovarian cancer, to share the stories of real women affected by the disease, to highlight the risk factors for ovarian cancer and educate Australians on ovarian cancer diagnosis and treatment.
You can take action during Awareness Month and beyond
- Talk to your friends, family to ensure they know ovarian cancer
- Ask your GP about your ovarian cancer risk
- Buy a $3 teal ribbon from the website
- Get an Awareness Kit to display at your GPs surgery or workplace
- Donate to help us save lives and support women
- Host a Paint the Town Teal event and raise funds to save lives and support women
Stay connected
Via Facebook, Instagram and Twitter to keep up to date with the latest news, research updates and events.
News & Trends - MedTech & Diagnostics
Government’s rejection of COVID Royal Commission a stark contrast to the UK and NZ
The Albanese government has dismissed the Senate legal and constitutional committee’s proposal for a COVID-19 pandemic royal commission with one […]
MoreNews & Trends - Biotechnology
AusBiotech and MTPConnect unite for landmark Summit on the nation’s biotech and medtech future
AusBiotech and MTPConnect have announced an ambitious new collaboration to host Australia’s first National Biotech and Medtech Development and Commercialisation […]
MoreNews & Trends - Pharmaceuticals
Targeted therapy with Astellas’ Xtandi improves prostate cancer outcomes for Aussie patients: New study
Pharma News: New research from the led by the Australian and New Zealand Urogenital and Prostate Cancer Trials Group (ANZUP) […]
More